期刊文献+

手术联合循环胸腔热灌注化疗治疗肺癌合并胸膜转移的生存分析 被引量:2

The Survival Analysis on Anatomic Resection and Postoperative Continuous Intrapleural Hyper-thermochemotherapy Perfusion in the Treatment of Lung Cancer with Pleural Metastasis
在线阅读 下载PDF
导出
摘要 目的探讨手术联合术后循环胸腔热灌注化疗治疗肺癌合并胸膜转移的临床疗效及预后因素。方法回顾性分析我院2007年7月~2012年12月行手术联合循环胸腔热灌注化疗的42例肺癌合并胸膜转移患者的临床资料,总结其预后,并进行单因素生存分析和多因素分析。结果 42例手术联合术后循环胸腔热灌注化疗治疗肺癌合并胸膜转移患者的中位生存期为28个月,1、2、3年的累计生存率分别为94.7%、68.5%、28.2%。单因素分析显示年龄、肿瘤病理类型、肿瘤直径、手术方式与预后无关(P〉0.05),而性别(χ2=5.773,P=0.016)、纵隔淋巴结状态(χ2=5.145,P=0.023)以及术前胸水情况(χ2=5.262,P=0.022)与术后生存相关。Cox预后多因素回归分析发现纵隔淋巴结情况(P=0.031)以及术前胸水情况(P=0.002)是影响预后的独立因素。结论应用手术联合循环胸腔热灌注化疗治疗肺癌合并胸膜转移安全有效。纵隔淋巴结情况以及术前胸水情况是影响预后的重要因素。 Objective To investigate the effects and clinical prognostic factors of resection and continuous intrapleural hyper-thermochemotherapy perfusion in the treatment of lung cancer with pleural metastasis. Methods The clinical data of 42 cases suffered lung cancer with pleural metastasis admitted from July 2007 to December 2012 were analyzed retrospectively. All cases were performed surgical intervention and postoperative continuous intrapleural hyper-thermochemotherapy perfusion. Results The median survival of all 42 patients was 28 months,and 1-,2- and 3-year accumulative survival rates was 94. 7%,68. 5% and 28. 2%,respectively. Univariate analysis revealed gender( χ2= 5. 773,P = 0. 016),mediastinal lymph nodal involvement( χ2= 5. 145,P = 0. 023) and preoperative malignant pleural effusion( χ2= 5. 262,P = 0. 022) were the related factors of postoperative survival,while age,pathological type of tumor,diameter of tumor and surgical procedure were not the correlation factor( P〉0. 05). Multivariate analysis showed that mediastinal lymph nodal involvement( P = 0. 031) and preoperative malignant pleural effusion status( P = 0. 002) were significant predictors for overall survival rate. Conclusions The combination therapy of the surgical procedure and postoperative continuous intrapleural hyper-thermochemotherapy perfusion may be a potentially curative treatment in selected patients of lung cancer with pleural dissemination. Patients with mediastinal nodal involvement and with malignant pleural effusion have significant worse overall survival rate.
出处 《中国现代手术学杂志》 2015年第4期241-245,共5页 Chinese Journal of Modern Operative Surgery
关键词 肺肿瘤 胸膜转移 胸腔积液 恶性 化学疗法 肿瘤 局部灌注 lung neoplasms pleural metastasis pleural effusion malignant chemotherapy cancer regional perfusion
  • 相关文献

参考文献2

二级参考文献29

  • 1Heffner JE. Diagnosis and management of malignant pleural effu- sions [ J ]. Respirology, 2008,13 ( 1 ) :5-20.
  • 2Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions[J]. Chest, 2000,117 ( 1 ) :79-86.
  • 3Davies HE, Mishra EK, Kahan BC, et al. Effect of indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion the TIME2 ran- domized controlled trial[ J]. Jama,2012,307 (22) :2383-2389.
  • 4Maceachern P, Tremblay A. Pleural controversy:pleurodesis ver- sus indwelling pleural catheters for malignant effusions[ J]. CancerInvest,2011,16 ( 5 ) : 747 -754.
  • 5Musani A1. Treatment option for malignant pleural effusion [J]. Curt Opin Pulm Med, 2009,15(4) :380-387.
  • 6Speetor M, Pollak JS. Management of malignant pleural effu- sions [J]. Semin Respir Crit Care,2008,29(4) :405-413.
  • 7Comert SS, Caglayan B, Parmaksiz ET, et al. Chemical pleurode- sis:from the point of view of pulmonary physicians and thoracic surgeons[J]. Turk Gogns Kalp Dama,2013,21 (2) :408-415.
  • 8Uzbeek MH, Almeida FA, Sarkiss MG, et al. Management of ma- lignant pleural effusions[J]. Adv Ther,2010,27(6) :334-347.
  • 9Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion effusion[ J]. Chest,2005,127:909-915.
  • 10Davies HE, Lee YC Gary. Management of malignant pleural effu- sions: questions that need answem[J]. Curr Opin Pulm Med, 2013,19(4) :374-379.

共引文献117

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部